The authors provide an overview of methods for the quantitative determination of genotoxic impurities (GTIs) in active pharmaceutical ingredients. Starting materials, reagents, intermediates, ...
The author provides a direction for identifying genotoxic impurities early in the drug development process, regulating genotoxic impurities at acceptable levels in the API or drug product, and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback